Developments in the field of antidepressants, where do we go now?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Neuropsychopharmacology

• Publication date

  2015-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.euroneuro.2013.04.013PMID 23706576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Probing and regulating dysfunctional circuits using deep brain stimulation.

  2013cited by this paper
• Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain.

  2013cited by this paper
• Serotonin receptors involved in antidepressant effects.

  2013cited by this paper
• Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor.

  2013cited by this paper
• Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

  2012cited by this paper
• Acute 5-HT1A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions

  2012cited by this paper
• Neural circuits underlying the pathophysiology of mood disorders.

  2012cited by this paper
• The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling.

  2012cited by this paper
• 5-HT2B receptors are required for serotonin-selective antidepressant actions

  2012cited by this paper
• Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression.

  2012cited by this paper
• Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression.

  2012cited by this paper
• Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

  2012cited by this paper
• Preclinical and clinical characterization of the selective 5‐HT1A receptor antagonist DU‐125530 for antidepressant treatment

  2012cited by this paper
• mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade.

  2012cited by this paper
• Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial.

  2012cited by this paper
• Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials

  2012cited by this paper
• Emerging drugs for major depressive disorder

  2012cited by this paper
• Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects

  2012cited by this paper
• A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia

  2011cited by this paper
• Cost of disorders of the brain in Europe 2010.

  2011cited by this paper
• Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.

  2011cited by this paper
• The serotonin-7 receptor as a novel therapeutic target.

  2010cited by this paper
• mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

  2010cited by this paper
• Preferential in vivo action of F15599, a novel 5‐HT1A receptor agonist, at postsynaptic 5‐HT1A receptors

  2010cited by this paper
• Adult Hippocampal Neurogenesis

  2010cited by this paper
• Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review

  2010cited by this paper
• Deep brain stimulation for treatment-resistant depression.

  2010cited by this paper
• Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations.

  2010cited by this paper
• Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats.

  2010cited by this paper
• Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.

  2010cited by this paper
• Metabotropic glutamate receptor 7: at the interface of cognition and emotion.

  2010cited by this paper
• F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists.

  2010cited by this paper
• The 5-HT7 receptor and disorders of the nervous system: an overview

  2009cited by this paper
• Augmentation strategies for treatment-resistant depression

  2009cited by this paper
• Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression

  2009cited by this paper
• Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.

  2009cited by this paper
• Pindolol augmentation enhances response outcomes in first depressive episodes.

  2009cited by this paper
• Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response

  2008cited by this paper
• Chronic Fluoxetine Bidirectionally Modulates Potentiating Effects of Serotonin on the Hippocampal Mossy Fiber Synaptic Transmission

  2008cited by this paper
• Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.

  2008cited by this paper
• Association of the COMT val158met Variant with Antidepressant Treatment Response in Major Depression

  2008cited by this paper
• Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.

  2008cited by this paper
• N-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-HT1A Agonist, as a Putative Mediator of Quetiapine's Antidepressant Activity

  2008cited by this paper
• Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

  2008cited by this paper
• Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report.

  2008cited by this paper
• Pharmacogenetic Analysis of Genes Implicated in Rodent Models of Antidepressant Response: Association of TREK1 and Treatment Resistance in the STAR*D Study

  2008cited by this paper
• Acute onset by 5-HT(6)-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression.

  2007cited by this paper
• Measurement of 5‐HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY‐100635

  2007cited by this paper
• Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients

  2007cited by this paper
• Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.

  2007cited by this paper
• Selective Blockade of 5-Hydroxytryptamine (5-HT)7 Receptors Enhances 5-HT Transmission, Antidepressant-Like Behavior, and Rapid Eye Movement Sleep Suppression Induced by Citalopram in Rodents

  2007cited by this paper
• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

  2007cited by this paper
• Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice.

  2007cited by this paper
• Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.

  2007cited by this paper
• Triple reuptake inhibitors ("broad spectrum" antidepressants).

  2007cited by this paper
• Adult hippocampal neurogenesis in depression

  2007cited by this paper
• Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.

  2007cited by this paper
• The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

  2007cited by this paper
• Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.

  2006cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• A neurotrophic model for stress-related mood disorders.

  2006cited by this paper
• New approaches to antidepressant drug discovery: beyond monoamines

  2006cited by this paper
• Placebo-controlled trial of agomelatine in the treatment of major depressive disorder.

  2006cited by this paper
• Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

  2006cited by this paper
• The mesolimbic dopamine reward circuit in depression.

  2006cited by this paper
• Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response

  2006cited by this paper
• Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study.

  2006cited by this paper
• Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

  2006cited by this paper
• Adaptive changes in serotonin neurons of the raphe nuclei in 5‐HT4 receptor knock‐out mouse

  2006cited by this paper
• Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).

  2006cited by this paper
• Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

  2006cited by this paper
• siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain

  2005cited by this paper
• Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Cost of disorders of the brain in Europe

  2005cited by this paper
• siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain

  2005cited by this paper
• Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers

  2005cited by this paper
• A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo.

  2005cited by this paper
• Deep brain stimulation for treatment-resistant depression.

  2005influential reference
• Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists.

  2005cited by this paper
• In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors.

  2004cited by this paper
• Investigation of serotonin-related genes in antidepressant response

  2004cited by this paper
• An autoradiographic study of the influence of pindolol upon [35S]GTPgammaS binding in rat, guinea pig and human brain.

  2004cited by this paper
• Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

  2004cited by this paper
• Prediction of Antidepressant Response to Milnacipran by Norepinephrine Transporter Gene Polymorphisms

  2004cited by this paper
• Limbic-frontal circuitry in major depression: a path modeling metanalysis

  2004cited by this paper
• Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex.

  2004cited by this paper
• Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635

  2004cited by this paper
• Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade

  2004cited by this paper
• Functional, molecular and pharmacological advances in 5-HT7 receptor research.

  2004cited by this paper
• The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder.

  2004cited by this paper
• Diencephalic and mesencephalic efferents of the medial prefrontal cortex in the rat: Electrophysiological evidence for the existence of branched axons

  2004cited by this paper
• Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA.

  2004cited by this paper
• Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression

  2004cited by this paper
• Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials.

  2004cited by this paper
• Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders.

  2003cited by this paper
• Synergistic Action of 5-HT2A Antagonists and Selective Serotonin Reuptake Inhibitors in Neuropsychiatric Disorders

  2003cited by this paper
• Is there a role for 5-HT1A agonists in the treatment of depression?

  2003cited by this paper
• Modulation of Serotonergic Function in Rat Brain by VN2222, a Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist

  2003cited by this paper
• Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

  2003cited by this paper
• Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide

  2003cited by this paper

• Associations between Kynurenine pathway metabolites and cognitive dysfunction in major depressive disorder

  2025cites this paper
• Citrus-caspase-4-serotonin axis: Aurantii Fructus rapidly reverses chronic-stress-induced despair via suppression of hippocampal caspase-4.

  2025cites this paper
• N-(3-((3-(trifluoromethyl)phenyl)selanyl)prop-2-yn-1-yl) benzamide induces antidepressant-like effect in mice: involvement of the serotonergic system

  2024cites this paper
• Serotonergic and Adrenergic Neuroreceptor Manipulation Ameliorates Core Symptoms of ADHD through Modulating Dopaminergic Receptors in Spontaneously Hypertensive Rats

  2024cites this paper
• Molecular Docking, MM-GBSA, and Molecular Dynamics Approach: 5-MeO-DMT Analogues as Potential Antidepressants.

  2023cites this paper
• Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase

  2023cites this paper
• Designing multi-target drugs for the treatment of major depressive disorder

  2023cites this paper
• Antidepressant effect of 4-Butyl-a-agarofuran via HPA axis and serotonin system.

  2023cites this paper
• Monoamine Oxidase: A Potential Link in Papez circuit to Generalized Anxiety Disorders.

  2023cites this paper
• Procognitive, Anxiolytic, and Antidepressant-like Properties of Hyperoside and Protocatechuic Acid Corresponding with the Increase in Serum Serotonin Level after Prolonged Treatment in Mice

  2023cites this paper
• Occlusal Disharmony—A Potential Factor Promoting Depression in a Rat Model

  2022cites this paper
• Preferential In Vivo Inhibitory Action of Serotonin in Rat Infralimbic versus Prelimbic Cortex: Relevance for Antidepressant Treatments.

  2022cites this paper
• The present study aimed to evaluate the antidepressant‐like effects of LIG via behavioral tests and to measure the levels of progesterone and allopregnanolone in the prefrontal cortex

  2021cites this paper
• Depression and the NMDA receptor/NO/cGMP pathway

  2021cites this paper
• Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?

  2021cites this paper
• Chemogenetics drives paradigm change in the investigation of behavioral circuits and neural mechanisms underlying drug action.

  2021cites this paper
• The Role of Central Serotonin Neurons and 5-HT Heteroreceptor Complexes in the Pathophysiology of Depression: A Historical Perspective and Future Prospects

  2021cites this paper
• Study of GPCR Homo- and Heteroreceptor Complexes in Specific Neuronal Cell Populations Using the In Situ Proximity Ligation Assay

  2021cites this paper
• 5-HT Receptors and the Development of New Antidepressants

  2021cites this paper
• Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia—Relevance for Mental Diseases

  2021cites this paper
• Antidepressant-like effects of Z-ligustilide on chronic unpredictable mild stress-induced depression in rats.

  2021cites this paper
• Inflammatory modulation of fluoxetine use in patients with depression: A systematic review and meta-analysis.

  2020cites this paper
• [Fluoxetine enhances combined learning and memory abilities of mice by promoting neural cell functions in the barrel cortex].

  2020cites this paper
• Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model

  2019cites this paper
• Anxiolytic‐like effects of the new arylpiperazine derivatives containing isonicotinic and picolinic nuclei: behavioral and biochemical studies

  2019cites this paper
• Regionally selective knockdown of astroglial glutamate transporters in infralimbic cortex induces a depressive phenotype in mice

  2019influential citation
• Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT1A receptor ligands.

  2019cites this paper
• New arylpiperazine derivatives with antidepressant-like activity containing isonicotinic and picolinic nuclei: evidence for serotonergic system involvement

  2019cites this paper
• Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT1A receptor ligands.

  2019cites this paper
• The microRNA-29a Modulates Serotonin 5-HT7 Receptor Expression and Its Effects on Hippocampal Neuronal Morphology

  2019cites this paper
• Novel antagonists of 5‐HT6 and/or 5‐HT7 receptors affect the brain monoamines metabolism and enhance the anti‐immobility activity of different antidepressants in rats

  2019cites this paper
• Astrocyte control of glutamatergic activity: Downstream effects on serotonergic function and emotional behavior.

  2019cites this paper
• In vivo knockdown of astroglial glutamate transporters GLT-1 and GLAST increases excitatory neurotransmission in mouse infralimbic cortex: Relevance for depressive-like phenotypes.

  2019cites this paper
• Detection, Analysis, and Quantification of GPCR Homo- and Heteroreceptor Complexes in Specific Neuronal Cell Populations Using the In Situ Proximity Ligation Assay

  2018cites this paper
• Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness

  2018cites this paper
• International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets

  2018cites this paper
• Short Term Intrarectal Administration of Sodium Propionate Induces Antidepressant-Like Effects in Rats Exposed to Chronic Unpredictable Mild Stress

  2018cites this paper
• Azapirones for the treatment of anxiety – an overview

  2018cites this paper
• Receptor–Receptor Interactions in Multiple 5-HT1A Heteroreceptor Complexes in Raphe-Hippocampal 5-HT Transmission and Their Relevance for Depression and Its Treatment

  2018influential citation
• Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy

  2018cites this paper
• Effects of Fluoxetine and Potential Antidepressant 8-Trifluoromethyl 1,2,3,4,5-Benzopentathiepin-6-Amine Hydrochloride (TC-2153) on Behavior of Danio rerio Fish in the Novel Tank Test and Brain Content of Biogenic Amines and Their Metabolites

  2018cites this paper
• Serotonin and brain function: a tale of two receptors

  2017cites this paper
• Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies.

  2017cites this paper
• Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease

  2017cites this paper
• Commentary: Deficient approaches to human neuroimaging

  2017influential citation
• Experimental occlusal disharmony – A promoting factor for anxiety in rats under chronic psychological stress

  2017influential citation
• Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile.

  2017cites this paper
• Antidepressant-like effects of Marasmius androsaceus metabolic exopolysaccharides on chronic unpredictable mild stress-induced rat model.

  2017cites this paper
• Dopamine and serotonin contribute to Paecilomyces hepiali against chronic unpredictable mild stress induced depressive behavior in Sprague Dawley rats.

  2017cites this paper
• Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

  2017cites this paper
• Existence of Brain 5-HT1A–5-HT2A Isoreceptor Complexes with Antagonistic Allosteric Receptor–Receptor Interactions Regulating 5-HT1A Receptor Recognition

  2017cites this paper
• Common neurotransmission recruited in (R,S)-ketamine and (2R,6R)-hydroxynorketamine-induced sustained antidepressant-like effects

  2017cites this paper
• Common Neurotransmission Recruited in (R,S)-Ketamine and (2R,6R)-Hydroxynorketamine-Induced Sustained Antidepressant-like Effects.

  2017cites this paper
• Editor’s note: The changing face of European Neuropsychopharmacology

  2016cites this paper
• Serotonin differentially modulates excitatory and inhibitory synaptic inputs to putative sleep-promoting neurons of the ventrolateral preoptic nucleus.

  2016cites this paper
• The emerging roles of human trace amines and human trace amine-associated receptors (hTAARs) in central nervous system.

  2016cites this paper
• Targeting the GABA B Receptor for the Treatment of Depression and Anxiety Disorders

  2016cites this paper
• Alterations in the neuropeptide galanin system in major depressive disorder involve levels of transcripts, methylation, and peptide

  2016cites this paper
• FGFR1-5-HT1A Heteroreceptor Complexes: Implications for Understanding and Treating Major Depression.

  2016cites this paper
• Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases

  2016cites this paper
• Epigenetic regulation of G protein coupled receptor signaling and its implications in psychiatric disorders.

  2016cites this paper
• Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration

  2016cites this paper
• Not only serotonergic system, but also dopaminergic system involved in albiflorin against chronic unpredictable mild stress-induced depression-like behavior in rats.

  2015cites this paper
• 5-HT 4 Receptor Subtype, β-Arrestin Level, and Rapid-Onset Effects of Antidepressant Drugs

  2015cites this paper
• Atypical Neurotransmitters and the Neurobiology of Depression.

  2015cites this paper
• Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands

  2015influential citation
• A Pontine Region is a Neural Correlate of the Human Affective Processing Network

  2015cites this paper
• Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review)

  2015cites this paper
• LIGANDY RECEPTORA 5-HT1A JAKO POTENCJALNE LEKI PRZECIWDEPRESYJNE

  2015cites this paper
• Synthesis and Evaluation of Antidepressant‐like Activity of Some 4‐Substituted 1‐(2‐methoxyphenyl)Piperazine Derivatives

  2015cites this paper
• GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?

  2015cites this paper
• Serotonin Receptor Technologies

  2015cites this paper
• 60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress.

  2015cites this paper
• Infralimbic cortex Rho-kinase inhibition causes antidepressant-like activity in rats.

  2015cites this paper
• Psychedelic symptoms of cannabis and cocaine use as a function of trait impulsivity

  2015cites this paper
• A Pontine Region is a Neural Correlate of the Human Affective Processing Network.

  2015cites this paper
• The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory

  2015cites this paper
• Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.

  2015cites this paper
• Neural Circuit Interactions between the Dorsal Raphe Nucleus and the Lateral Hypothalamus: An Experimental and Computational Study

  2014cites this paper
• Ketamine and Depression: A Review

  2014influential citation
• The highs and lows of drugs use: acute effects of cannabis, cocaine and MDMA on impulsivity, cognition and subjective experience

  2014cites this paper
• It is Possible Find an Antidepressant with Faster Onset of Action? Ketamine: Promise or Reality?

  2014cites this paper
• Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance.

  2014influential citation
• Rapid Anxiolytic Effects of a 5-HT4 Receptor Agonist Are Mediated by a Neurogenesis-Independent Mechanism

  2014cites this paper
• Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression.

  2014cites this paper
• β-phenylethylamine, a small molecule with a large impact.

  2013cites this paper
• Central 5‐HT1A receptor‐mediated modulation of heart rate dynamics and its adjustment by conditioned and unconditioned fear in mice

  2013cites this paper